Expression of serum NEAT1, miR-129-5p, and their related targets BCL2 and TGF-β1 didn’t differ significantly among PC cases with different pN stages (P = 0.4, 0.71, 0.77, and 0.08, respectively). This evidence concerns the gene BCL2 and pachyonychia congenita.